Yüklüyor......
Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China
Peripheral T-cell lymphoma (PTCL) is a set of rare and highly heterogeneous group of mature T- and NK-cell neoplasms associated with poor outcomes and lack of standard and effective therapies. The total number of newly diagnosed cases of PTCL yearly in China is estimated about 50,000. Chidamide (CS0...
Kaydedildi:
| Yayımlandı: | Intractable Rare Dis Res |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
International Research and Cooperation Association for Bio & Socio-Sciences Advancement
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4995415/ https://ncbi.nlm.nih.gov/pubmed/27672541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5582/irdr.2016.01024 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|